Schizophrenia as dopamine-deficiency disease (Q48175087)

9 February 2018

title

Schizophrenia as dopamine-deficiency disease (English)

1 reference

9 February 2018

0 references

0 references

G Chouinard

1

1 reference

9 February 2018

B D Jones

series ordinal

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1978

1 reference

9 February 2018

published in

The Lancet

1 reference

9 February 2018

volume

2

1 reference

9 February 2018

issue

8080

1 reference

9 February 2018

page(s)

99-100

1 reference

9 February 2018

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

Concept and classification of schizophrenia in the Soviet Union

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

1 reference

7 January 2021

Behavioral effects of l-Dopa in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

Antidepressant drug levels and clinical response

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(78)91409-5

7 January 2021

10.1016/S0140-6736(78)91409-5

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018